SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED

Altre lingue Shanghai HeartCare Medical Technology Corporation Limited

Azioni

6609

CNE100004MN5

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:06 30/04/2024			Variaz. 5gg	Var. 1 gen.
17,9 ^HKD	-3,87%		+8,35%	-39,83%

28/03	Shanghai HeartCare Medical Technology Corporation Limited riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Shanghai Heartcare Medical Technology Corporation Limited nomina Xue Zongyu come presidente del Comitato di Vigilanza	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical	12/12
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee	17/11
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes	08/11
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index	18/09/23
HeartCare Medical Technology's Loss Narrows in H1	01/09/23
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes	20/03/23
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director	09/11/22
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director	31/08/22
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/08/22
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/08/22
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/08/22
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director	15/07/22
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director	10/06/22
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder	28/04/22
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter	26/04/22
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shanghai HeartCare Medical Technology Corporation Limited

Azioni

6609

CNE100004MN5

Altre lingue

Filtri